TY - JOUR
T1 - Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia
AU - Brien, Rita
AU - Volpe, Isabelle
AU - Grigg, Jasmin
AU - Lyons, Tom
AU - Hughes, Caitlin
AU - McKinnon, Ginny
AU - Tzanetis, Stephanie
AU - Crawford, Sione
AU - Eade, Alan
AU - Lee, Nicole
AU - Barratt, Monica J.
N1 - Funding Information:
We gratefully acknowledge the research participants who contributed to this project and project partners who have supported research operations. We acknowledge with respect the Traditional Custodians of the lands and waterways where we live and work, the Wurrundjeri and Bunurong People of the Kulin Nations Alliance and Clans of Dja Dja Wurrung Country in Victoria; the People of Ngunnawal Country in ACT; and the Kaurna People of South Australia. The positions and opinions described in this paper are held by the authors and do not necessarily represent those of the organisations with which they are affiliated.
Funding Information:
This project is supported by funding from the National Centre for Clinical Research on Emerging Drugs (NCCRED), funded by the Australian Government Department of Health. The funding body did not play any role in study design, data collection, data analysis, data interpretation or manuscript writing.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3/9
Y1 - 2023/3/9
N2 - Background: Alerts about changes in unregulated drug markets may be useful for supporting health and community workers to anticipate, prevent, and respond to unexpected adverse drug events. This study aimed to establish factors influencing the successful design and implementation of drug alerts for use in clinical and community service settings in Victoria, Australia. Methods: An iterative mixed methods design was used to co-produce drug alert prototypes with practitioners and managers working across various alcohol and other drug services and emergency medicine settings. A quantitative needs-analysis survey (n = 184) informed five qualitative co-design workshops (n = 31). Alert prototypes were drafted based on findings and tested for utility and acceptability. Applicable constructs from the Consolidated Framework for Implementation Research helped to conceptualise factors that impact successful alert system design. Results: Timely and reliable alerts about unexpected drug market changes were important to nearly all workers (98%) yet many reported insufficient access to this kind of information (64%). Workers considered themselves ‘conduits’ for information-sharing and valued alerts for increasing exposure to drug market intelligence; facilitating communication about potential threats and trends; and improving capacity for effective responding to drug-related harm. Alerts should be ‘shareable’ across a range of clinical and community settings and audiences. To maximise engagement and impact, alerts must command attention, be easily recognisable, be available on multiple platforms (electronic and printable formats) in varying levels of detail, and be disseminated via appropriate notification mechanisms to meet the needs of diverse stakeholder groups. Three drug alert prototypes (SMS prompt, summary flyer, and a detailed poster) were endorsed by workers as useful for supporting their work responding to unexpected drug-related harms. Discussion: Alerts informed by coordinated early warning networks that offer close to real-time detection of unexpected substances can provide rapid, evidence-based drug market intelligence to inform preventive and responsive action to drug-related harm. The success of alert systems requires adequate planning and resourcing to support design, implementation, and evaluation, which includes consultation with all relevant audiences to understand how to maximise engagement with information, recommendations, and advice. Our findings about factors impacting successful alert design have utility to inform the development of local early warning systems.
AB - Background: Alerts about changes in unregulated drug markets may be useful for supporting health and community workers to anticipate, prevent, and respond to unexpected adverse drug events. This study aimed to establish factors influencing the successful design and implementation of drug alerts for use in clinical and community service settings in Victoria, Australia. Methods: An iterative mixed methods design was used to co-produce drug alert prototypes with practitioners and managers working across various alcohol and other drug services and emergency medicine settings. A quantitative needs-analysis survey (n = 184) informed five qualitative co-design workshops (n = 31). Alert prototypes were drafted based on findings and tested for utility and acceptability. Applicable constructs from the Consolidated Framework for Implementation Research helped to conceptualise factors that impact successful alert system design. Results: Timely and reliable alerts about unexpected drug market changes were important to nearly all workers (98%) yet many reported insufficient access to this kind of information (64%). Workers considered themselves ‘conduits’ for information-sharing and valued alerts for increasing exposure to drug market intelligence; facilitating communication about potential threats and trends; and improving capacity for effective responding to drug-related harm. Alerts should be ‘shareable’ across a range of clinical and community settings and audiences. To maximise engagement and impact, alerts must command attention, be easily recognisable, be available on multiple platforms (electronic and printable formats) in varying levels of detail, and be disseminated via appropriate notification mechanisms to meet the needs of diverse stakeholder groups. Three drug alert prototypes (SMS prompt, summary flyer, and a detailed poster) were endorsed by workers as useful for supporting their work responding to unexpected drug-related harms. Discussion: Alerts informed by coordinated early warning networks that offer close to real-time detection of unexpected substances can provide rapid, evidence-based drug market intelligence to inform preventive and responsive action to drug-related harm. The success of alert systems requires adequate planning and resourcing to support design, implementation, and evaluation, which includes consultation with all relevant audiences to understand how to maximise engagement with information, recommendations, and advice. Our findings about factors impacting successful alert design have utility to inform the development of local early warning systems.
KW - Drug alerts
KW - Early warning systems
KW - Emerging drugs
KW - Harm reduction
UR - http://www.scopus.com/inward/record.url?scp=85149671713&partnerID=8YFLogxK
U2 - 10.1186/s12954-023-00761-6
DO - 10.1186/s12954-023-00761-6
M3 - Article
C2 - 36894933
AN - SCOPUS:85149671713
SN - 1477-7517
VL - 20
JO - Harm Reduction Journal
JF - Harm Reduction Journal
IS - 1
M1 - 30
ER -